Which groups of people are not suitable for taking ivonib?

Ivosidenib (Ivosidenib) is a targeted drug mainly used to treat specific types of cancer, especially mutant acute myeloid leukemia (AML). Although this drug is effective for many patients, it may not be suitable for certain groups of people. The following are some groups of people who are not suitable for ivosidenib.

First, ivonib should be used with caution in patients with hepatic impairment. Because this drug is metabolized by the liver, patients with impaired liver function may not be able to metabolize the drug efficiently, thereby increasing drug concentrations and increasing the risk of adverse reactions. Especially in patients with severe hepatic impairment (such as cirrhosis or liver failure), the use of ivosidenib should be avoided or the dose should be adjusted under strict supervision by a physician.

Secondly, ivonib may be potentially harmful to pregnant women. Animal experiments have shown that this drug may have adverse effects on the fetus, so pregnant women should avoid using this drug. For women requiring treatment during pregnancy, physicians should consider whether there are safer alternatives. If a patient becomes pregnant while taking ivosidenib, she should stop taking the medication immediately and talk to her doctor about taking appropriate measures.

In addition, lactating women should also be cautious when using ivonib. It is not known whether this drug is excreted in breast milk, so using this drug during breastfeeding may affect the health of the infant. To avoid potential risks, breastfeeding women should avoid using ivosidenib or stop breastfeeding while taking the drug and consult their doctor about appropriate alternatives.

Finally, ivosidenib may interact with certain medications, particularly those that affect the activity of liver enzymes. Therefore, patients who are taking other drugs (such as strong CYP3A inhibitors or inducers) should inform their doctors about all the drugs they are taking and adjust their treatment plan under the guidance of their doctors. For patients with a history of drug allergy, allergic reaction screening should also be performed before starting to use ivonib to prevent the occurrence of adverse reactions.

Reference link:https://www.tibsovo.com/